Kasi Russell-Lodrigue Selected Research

Kasi Russell-Lodrigue Research Topics

13	Infections 01/2022 - 08/2011
5	COVID-19 01/2022 - 01/2021
4	Viremia 01/2021 - 06/2013
2	Melioidosis 05/2014 - 01/2014
1	Hypoxia (Hypoxemia) 01/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Virus Diseases (Viral Diseases) 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Enterocolitis 01/2018
1	Glanders 12/2017
1	Fever (Fevers) 12/2014
1	Sepsis (Septicemia) 05/2014

6	VaccinesIBA 01/2022 - 01/2014
3	AerosolsIBA 01/2022 - 08/2011
3	cabotegravirIBA 01/2017 - 03/2014
2	aluminum sulfate (alum)IBA 02/2021 - 01/2021
2	Neutralizing AntibodiesIBA 01/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2014 - 06/2013
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Virus-Like Particle VaccinesIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2021
1	Viral DNAIBA 01/2021
1	ogalvibartIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020
1	rifapentine (Priftin)FDA Link 01/2020
1	IceIBA 01/2018
1	Immunoglobulin G (IgG)IBA 12/2017
1	InterferonsIBA 12/2014
1	Combined VaccinesIBA 05/2014
1	Integrase InhibitorsIBA 01/2014
1	L870812IBA 01/2014
1	RacivirIBA 01/2014
1	Reverse Transcriptase InhibitorsIBA 01/2014
1	AIDS VaccinesIBA 06/2013

4	Therapeutics 01/2022 - 01/2018
1	Euthanasia (Mercy Killing) 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Blood Transfusion (Blood Transfusions) 01/2017
1	Highly Active Antiretroviral Therapy (HAART) 01/2014